TY - JOUR
T1 - Respiratory manifestations in the Ehlers–Danlos syndromes
AU - Bascom, Rebecca
AU - Dhingra, Radha
AU - Francomano, Clair A.
N1 - Funding Information:
Rebecca Bascom and Radha Dhingra have no disclosures. Clair A. Francomano is in part funded by the Ehlers‐Danlos Society.
Funding Information:
Jane R. Schubart, Max Whitehead‐Zimmers, Alan Hakim, Lara Bloom, Penn State University EDS Patient Research Advisory Group (Susan Mills, PSU EDS PRAG facilitator). The project described was supported by PCORI Eugene Washington Engagement Award Project, 2018. Penn State Clinical and Translational Science Institute's Bridges to Translation Pilot Grant Program, 2018. The National Institute on Aging Intramural Research Program and by the National Center for Advancing Translational Sciences, National Institutes of Health, United States, through grant UL1 TR002014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Funding Information:
Jane R. Schubart, Max Whitehead-Zimmers, Alan Hakim, Lara Bloom, Penn State University EDS Patient Research Advisory Group (Susan Mills, PSU EDS PRAG facilitator). The project described was supported by PCORI Eugene Washington Engagement Award Project, 2018. Penn State Clinical and Translational Science Institute's Bridges to Translation Pilot Grant Program, 2018. The National Institute on Aging Intramural Research Program and by the National Center for Advancing Translational Sciences, National Institutes of Health, United States, through grant UL1 TR002014. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Publisher Copyright:
© 2021 Wiley Periodicals LLC.
PY - 2021/12
Y1 - 2021/12
N2 - Persons with the Ehlers–Danlos syndromes (EDS) report a wide range of respiratory symptoms, most commonly shortness of breath, exercise limitation, and cough. Also reported are noisy breathing attributed to asthma, difficulty with deep inhalation, and inspiratory thoracic pain. The literature consists of case reports and small cross-sectional and cohort studies. One case–control study estimated twofold to threefold greater respiratory disease burden among persons with EDS as compared to controls. The differential diagnosis for symptoms is broad. Structural alterations include pectus deformities, scoliosis, recurrent rib subluxations, and tracheobronchomalacia, associated with varying degrees of physiologic impairment. Those with vascular EDS have an increased risk of pneumothorax, intrapulmonary bleeding, cysts, and nonmalignant fibrous nodules. Functional aerodigestive manifestations such as inducible laryngeal obstruction may be misdiagnosed as asthma, with gastro-esophageal dysmotility and reflux as common contributing factors. Inflammatory manifestations include costochondritis, bronchiectasis, and localized respiratory allergic and nonallergic mast cell activation. Cranio-cervical instability can dysregulate respiratory control pathways. There is a need for careful phenotyping using standardized clinical tools and patient-reported outcomes and continuing collaboration with aerodigestive specialists including otolaryngologists and gastroenterologists. Also needed is further evaluation of respiratory symptoms in persons with hypermobility spectrum disorders. Personalized monitoring strategies are invaluable for interpretation and long-term management of respiratory symptoms.
AB - Persons with the Ehlers–Danlos syndromes (EDS) report a wide range of respiratory symptoms, most commonly shortness of breath, exercise limitation, and cough. Also reported are noisy breathing attributed to asthma, difficulty with deep inhalation, and inspiratory thoracic pain. The literature consists of case reports and small cross-sectional and cohort studies. One case–control study estimated twofold to threefold greater respiratory disease burden among persons with EDS as compared to controls. The differential diagnosis for symptoms is broad. Structural alterations include pectus deformities, scoliosis, recurrent rib subluxations, and tracheobronchomalacia, associated with varying degrees of physiologic impairment. Those with vascular EDS have an increased risk of pneumothorax, intrapulmonary bleeding, cysts, and nonmalignant fibrous nodules. Functional aerodigestive manifestations such as inducible laryngeal obstruction may be misdiagnosed as asthma, with gastro-esophageal dysmotility and reflux as common contributing factors. Inflammatory manifestations include costochondritis, bronchiectasis, and localized respiratory allergic and nonallergic mast cell activation. Cranio-cervical instability can dysregulate respiratory control pathways. There is a need for careful phenotyping using standardized clinical tools and patient-reported outcomes and continuing collaboration with aerodigestive specialists including otolaryngologists and gastroenterologists. Also needed is further evaluation of respiratory symptoms in persons with hypermobility spectrum disorders. Personalized monitoring strategies are invaluable for interpretation and long-term management of respiratory symptoms.
UR - http://www.scopus.com/inward/record.url?scp=85119657577&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85119657577&partnerID=8YFLogxK
U2 - 10.1002/ajmg.c.31953
DO - 10.1002/ajmg.c.31953
M3 - Review article
C2 - 34811894
AN - SCOPUS:85119657577
SN - 0897-4438
VL - 187
SP - 533
EP - 548
JO - American Journal of Medical Genetics, Part C: Seminars in Medical Genetics
JF - American Journal of Medical Genetics, Part C: Seminars in Medical Genetics
IS - 4
ER -